JP2009517381A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009517381A5 JP2009517381A5 JP2008542245A JP2008542245A JP2009517381A5 JP 2009517381 A5 JP2009517381 A5 JP 2009517381A5 JP 2008542245 A JP2008542245 A JP 2008542245A JP 2008542245 A JP2008542245 A JP 2008542245A JP 2009517381 A5 JP2009517381 A5 JP 2009517381A5
- Authority
- JP
- Japan
- Prior art keywords
- uch
- inhibitor
- cancer metastasis
- composition
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020050113101A KR100732298B1 (ko) | 2005-11-24 | 2005-11-24 | 유비키틴 ｃ-말단 가수분해제-ｌ1을 이용한 암전이 진단용조성물 |
| PCT/KR2006/004989 WO2007061256A1 (en) | 2005-11-24 | 2006-11-24 | Novel use of ubiquitin c-terminal hydrolase-l1 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009517381A JP2009517381A (ja) | 2009-04-30 |
| JP2009517381A5 true JP2009517381A5 (https=) | 2010-04-08 |
Family
ID=38067427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008542245A Pending JP2009517381A (ja) | 2005-11-24 | 2006-11-24 | ユビキチンｃ末端ヒドロラーゼ−ｌ１の新規な使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090208508A1 (https=) |
| EP (1) | EP1993581A4 (https=) |
| JP (1) | JP2009517381A (https=) |
| KR (1) | KR100732298B1 (https=) |
| CN (1) | CN101316605A (https=) |
| WO (1) | WO2007061256A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009027349A2 (en) * | 2007-08-24 | 2009-03-05 | Oryzon Genomics Sa | Treatment and prevention of neurodegenerative diseases |
| WO2010123365A1 (en) * | 2009-04-24 | 2010-10-28 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Increasing the immunogenicity of epithelial cells infected with human papilloma virus (hpv) |
| KR101384642B1 (ko) * | 2012-06-22 | 2014-04-22 | 이화여자대학교 산학협력단 | Ｎ―말단이 제거된 유비퀴틴 ｃ―말단 가수분해효소―ｌ１（ｎｔ―ｕｃｈ―ｌ１）를 유효성분으로 포함하는 파킨슨병 예방 및 치료용 약학적 조성물 |
| WO2014185561A1 (ko) * | 2013-05-13 | 2014-11-20 | 이화여자대학교 산학협력단 | 신규한 화합물 또는 이의 약학적으로 허용 가능한 염 및 이를 유효성분으로 함유하는 ｕｃｈ－ｌ１ 관련 질환의 예방 또는 치료용 약학적 조성물 |
| EP3887831A1 (en) | 2018-11-26 | 2021-10-06 | Baseline Global, Inc. | Methods, systems, and a kit for diagnosis, detection, monitoring and treatment of traumatic brain injury |
| CN110684740B (zh) * | 2019-08-09 | 2020-12-08 | 无锡傲锐东源生物科技有限公司 | 一种抗人泛素羧基末端水解酶-1(uch-l1)的单克隆抗体及其应用 |
| CN112891542B (zh) * | 2021-02-01 | 2021-11-16 | 暨南大学 | 一种包含UCHs抑制剂的药物组合物及其应用 |
| CN113970643B (zh) * | 2021-11-23 | 2023-06-30 | 北京大学人民医院 | 检测抗uch-l1表位的自身抗体的试剂在制备sle血清诊断相关产品中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69837529T2 (de) * | 1997-02-12 | 2007-07-26 | Electrophoretics Ltd., Cobham | Proteinmarker für lungenkrebs und deren verwendung |
| KR100545076B1 (ko) | 2003-01-27 | 2006-01-24 | 김현기 | 인간 원암유전자 ｈｐｐ1 및 이에 의해 코드되는 단백질 |
| US7319010B2 (en) * | 2003-05-12 | 2008-01-15 | The Regents Of The University Of Michigan | Detection and treatment of cancers of the colon |
| KR100520800B1 (ko) | 2003-05-19 | 2005-10-12 | 김진우 | 인간 원암유전자 ｐｉｇ２ 및 이에 의해 코드되는 단백질 |
| JP2005272350A (ja) * | 2004-03-24 | 2005-10-06 | Vitamin C60 Bioresearch Kk | 癌転移阻害剤 |
-
2005
- 2005-11-24 KR KR1020050113101A patent/KR100732298B1/ko not_active Expired - Fee Related
-
2006
- 2006-11-24 EP EP06843893A patent/EP1993581A4/en not_active Withdrawn
- 2006-11-24 CN CNA2006800437290A patent/CN101316605A/zh active Pending
- 2006-11-24 JP JP2008542245A patent/JP2009517381A/ja active Pending
- 2006-11-24 WO PCT/KR2006/004989 patent/WO2007061256A1/en not_active Ceased
- 2006-11-24 US US12/094,955 patent/US20090208508A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bonne et al. | Salivary biomarker development using genomic, proteomic and metabolomic approaches | |
| Morshed et al. | Neutral antibodies to the TSH receptor are present in Graves’ disease and regulate selective signaling cascades | |
| CN102667472B (zh) | Tivozanib应答预测 | |
| JP2012526554A5 (https=) | ||
| JP2015533788A5 (https=) | ||
| JP2017524130A5 (https=) | ||
| JP2014508298A5 (https=) | ||
| Qiu et al. | ANKRD22 is involved in the progression of prostate cancer | |
| JP2018049033A (ja) | リシルオキシダーゼ様２のアッセイおよびその使用の方法 | |
| JP2012501452A5 (https=) | ||
| JP2016506362A (ja) | 合成致死性および癌の治療 | |
| JP2009509517A (ja) | 肝細胞癌の分子マーカーおよびそれらの利用 | |
| CN102459642A (zh) | 采用可检测蛋白质的细胞测定法 | |
| JP2014503191A5 (https=) | ||
| CN102472753B (zh) | 基于组蛋白macroH2A同工型预测癌症复发风险的诊断方法 | |
| JP2009517381A5 (https=) | ||
| CA3195344A1 (en) | Improved assays to quantify chromatin targets using antibody-targeted enzyme digestion | |
| JP2010535506A5 (https=) | ||
| An et al. | Detection of tyrosine hydroxylase in dopaminergic neuron cell using gold nanoparticles-based barcode DNA | |
| CN102947446B (zh) | 肺腺癌的预后预测方法、肺腺癌的检测试剂盒以及用于治疗肺腺癌的医药组合物 | |
| JP2005047895A (ja) | Ｈｃｖ調節タンパク質 | |
| EP2601528B1 (en) | Novel methods for predicting the responsiveness of a patient affected with a tumor to a treatment with a tyrosine kinase inhibitor | |
| CN107615071B (zh) | 用于包含乐伐替尼和依维莫司的联合疗法的生物标志 | |
| KR101670135B1 (ko) | 리포칼린 2 단백질에 특이적으로 결합하는 dna 앱타머 및 이의 용도 | |
| US20120156681A1 (en) | Composition for diagnosis of liver metastasis of colorectal cancer and the use thereof |